CVE-2023-31412

Description

The LMS5xx uses weak hash generation methods, resulting in the creation of insecure hashs. If an attacker manages to retrieve the hash, it could lead to collision attacks and the potential retrieval of the password.

Remediation

Workaround:

  • Please make sure that you apply general security practices when operating the LMS5xx. The following General Security Practices and Operating Guidelines could mitigate the associated security risk. It is also recommended to apply the security practices listed in the LMS5xx hardening guide.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.09%
Vendor Advisory sick.com Vendor Advisory sick.com Vendor Advisory sick.com
Affected: SICK AG LMS5xx
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-31412?
CVE-2023-31412 has been scored as a high severity vulnerability.
How to fix CVE-2023-31412?
As a workaround for remediating CVE-2023-31412: Please make sure that you apply general security practices when operating the LMS5xx. The following General Security Practices and Operating Guidelines could mitigate the associated security risk. It is also recommended to apply the security practices listed in the LMS5xx hardening guide.
Is CVE-2023-31412 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-31412 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-31412?
CVE-2023-31412 affects SICK AG LMS5xx.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.